Cryo-Cell International Inc.

CCEL Healthcare Medical Care Facilities

Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024. In the quarter to August 2026, revenue was flat, EPS grew 77.8%, free cash flow fell 58.4% and total debt fell 29.5%, each against the same quarter a year earlier.

4.42 0.77 +21.10%
Market cap
$29.4M
P/E
0.0×
Fwd P/E
43.8×
Dividend yield
0.00%
F-score
6/9
Altman Z
−0.23
Beneish M
−3.17
Dividend safety
20/100
Older periods Nov '25 Feb '26 May '26 Aug '26
Piotroski F-Score

+8 more TTM periods

6 6 6 6
ROE
15.27% 16.12% 14.80% 12.46%
ROA
(3.84%) (4.26%) (3.94%) (3.10%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(18.69%) (18.79%) (15.37%) (10.58%)
Average Days of Receivables
79.16 79.53 81.03 80.14
Free Cash Flow per Share
0.66 0.63 0.76 0.58
Free Cash Flow
5.36 5.06 6.11 4.65
Other line items

Show all line items

Columns are period end dates · fundamentals updated 15 Oct 2026